218 related articles for article (PubMed ID: 33859739)
1. Preventing tumor progression to the bone by induced tumor-suppressing MSCs.
Sun X; Li K; Zha R; Liu S; Fan Y; Wu D; Hase M; Aryal UK; Lin CC; Li BY; Yokota H
Theranostics; 2021; 11(11):5143-5159. PubMed ID: 33859739
[No Abstract] [Full Text] [Related]
2. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
Theranostics; 2022; 12(2):929-943. PubMed ID: 34976221
[No Abstract] [Full Text] [Related]
3. Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs.
Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
[No Abstract] [Full Text] [Related]
4. Osteocyte-Driven Downregulation of Snail Restrains Effects of Drd2 Inhibitors on Mammary Tumor Cells.
Liu S; Fan Y; Chen A; Jalali A; Minami K; Ogawa K; Nakshatri H; Li BY; Yokota H
Cancer Res; 2018 Jul; 78(14):3865-3876. PubMed ID: 29769195
[TBL] [Abstract][Full Text] [Related]
5. In vivo fluorescence imaging reveals the promotion of mammary tumorigenesis by mesenchymal stromal cells.
Ke CC; Liu RS; Suetsugu A; Kimura H; Ho JH; Lee OK; Hoffman RM
PLoS One; 2013; 8(7):e69658. PubMed ID: 23936067
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Growth of Breast Cancer-Associated Brain Tumors by the Osteocyte-Derived Conditioned Medium.
Sano T; Sun X; Feng Y; Liu S; Hase M; Fan Y; Zha R; Wu D; Aryal UK; Li BY; Sudo A; Yokota H
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802279
[TBL] [Abstract][Full Text] [Related]
7. Generation of the tumor-suppressive secretome from tumor cells.
Liu S; Sun X; Li K; Zha R; Feng Y; Sano T; Dong C; Liu Y; Aryal UK; Sudo A; Li BY; Yokota H
Theranostics; 2021; 11(17):8517-8534. PubMed ID: 34373756
[No Abstract] [Full Text] [Related]
8. PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9.
Sun X; Li K; Aryal UK; Li BY; Yokota H
Mol Ther Oncolytics; 2022 Sep; 26():360-371. PubMed ID: 36090473
[TBL] [Abstract][Full Text] [Related]
9. Mutations in bone marrow-derived stromal stem cells unmask latent malignancy.
Houghton J; Li H; Fan X; Liu Y; Liu JH; Rao VP; Poutahidis T; Taylor CL; Jackson EA; Hewes C; Lyle S; Cerny A; Bowen G; Cerny J; Moore N; Kurt-Jones EA; Erdman SE
Stem Cells Dev; 2010 Aug; 19(8):1153-66. PubMed ID: 20199238
[TBL] [Abstract][Full Text] [Related]
10. Enhancing anti-tumor potential: low-intensity vibration suppresses osteosarcoma progression and augments MSCs' tumor-suppressive abilities.
Xiong X; Huo Q; Li K; Cui C; Chang C; Park C; Ku B; Hong CS; Lim H; Pandya PH; Saadatzadeh MR; Bijangi-Vishehsaraei K; Lin CC; Kacena MA; Pollok KE; Chen A; Liu J; Thompson WR; Li XL; Li BY; Yokota H
Theranostics; 2024; 14(4):1430-1449. PubMed ID: 38389836
[No Abstract] [Full Text] [Related]
11. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
Boucharaba A; Serre CM; Grès S; Saulnier-Blache JS; Bordet JC; Guglielmi J; Clézardin P; Peyruchaud O
J Clin Invest; 2004 Dec; 114(12):1714-25. PubMed ID: 15599396
[TBL] [Abstract][Full Text] [Related]
12. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
[TBL] [Abstract][Full Text] [Related]
13. Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis.
Li K; Sun X; Minami K; Tamari K; Ogawa K; Li H; Ma H; Zhou M; Na S; Li BY; Yokota H
Theranostics; 2023; 13(4):1247-1263. PubMed ID: 36923539
[No Abstract] [Full Text] [Related]
14. Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
Marino S; Bishop RT; Mollat P; Idris AI
Calcif Tissue Int; 2018 Aug; 103(2):206-216. PubMed ID: 29455416
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells.
Molloy AP; Martin FT; Dwyer RM; Griffin TP; Murphy M; Barry FP; O'Brien T; Kerin MJ
Int J Cancer; 2009 Jan; 124(2):326-32. PubMed ID: 19003962
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect.
Wang ML; Pan CM; Chiou SH; Chen WH; Chang HY; Lee OK; Hsu HS; Wu CW
Cancer Res; 2012 Nov; 72(22):6051-64. PubMed ID: 23139208
[TBL] [Abstract][Full Text] [Related]
17. MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway.
He N; Kong Y; Lei X; Liu Y; Wang J; Xu C; Wang Y; Du L; Ji K; Wang Q; Li Z; Liu Q
Cell Death Dis; 2018 Oct; 9(10):1026. PubMed ID: 30297887
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors.
Zhang T; Lee YW; Rui YF; Cheng TY; Jiang XH; Li G
Stem Cell Res Ther; 2013 Jun; 4(3):70. PubMed ID: 23763837
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin on human bone-derived mesenchymal stromal cell-breast cancer cell line interactions.
Teufelsbauer M; Lang C; Plangger A; Rath B; Moser D; Staud C; Radtke C; Neumayer C; Hamilton G
Med Oncol; 2022 Feb; 39(5):54. PubMed ID: 35150338
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory Effects of Dopamine Receptor D
Minami K; Liu S; Liu Y; Chen A; Wan Q; Na S; Li BY; Matsuura N; Koizumi M; Yin Y; Gan L; Xu A; Li J; Nakshatri H; Yokota H
Sci Rep; 2017 Apr; 7():45686. PubMed ID: 28374823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
